Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 11 - General Provisions › 12 AAC 52.995 - Definitions

Current through May 31, 2024
(a) In this
				  chapter, unless the context requires otherwise,
(1) "ACPE" means Accreditation Council for
				  Pharmacy Education;
(2) "approved
				  program" means a continuing education activity that is a live program, home
				  study, or other mediated instruction delivered by an approved or accredited
				  provider;
(3) "approved provider"
				  means an individual, institution, organization, association, corporation, or
				  agency offering an approved program under
				  12 AAC 52.340 and is not an
				  accredited provider;
(4)
				  "authorized inspector" means a member of the board or an investigator with the
				  division assigned occupational licensing functions in the department;
(5) "blood" means whole blood collected from
				  a single donor and processed either for transfusion or further
				  manufacturing;
(6) "blood
				  component" means that part of blood separated by physical or mechanical
				  means;
(7) "board" means the Alaska
				  Board of Pharmacy;
(8) "care
				  provider" means a person or organization that by the nature of experience and
				  training is qualified, in the opinion of the board, to provide substance abuse
				  counseling, rehabilitation, or related services to the public through
				  established and recognized treatment programs;
(9) "consultant pharmacist" means a licensed
				  pharmacist retained by written agreement with an institutional facility to
				  consult on a routine basis with an institutional facility about the practice of
				  pharmacy as it relates to that facility;
(10) "contact hour" means a unit of measure
				  of educational credit that is equivalent to approximately 50 minutes of
				  participation in an organized learning experience; a continuing education unit
				  or "CEU" is equivalent to ten contact hours;
(11) "DEA" means the United States Drug
				  Enforcement Administration;
(12)
				  "department" means the Department of Commerce, Community, and Economic
				  Development;
(13) "direct
				  supervision" means supervision that ensures adequate safety controls either by
				  personal supervision or through a telepharmacy system;
(14) "home study" and "other mediated
				  instruction" mean continuing education activities that are not conducted as
				  live programs, including audio tapes, video tapes, television, computer
				  assisted instruction, journal articles, or monographs;
(15) "institutional facility" means a
(A) hospital;
(B) long-term care facility, including a
				  nursing home, convalescent home, or other related facility;
(C) mental health facility;
(D) rehabilitation center;
(E) psychiatric center;
(F) developmental disability
				  center;
(G) drug abuse treatment
				  center;
(H) family planning
				  clinic;
(I) penal
				  institution;
(J) hospice;
				  or
(K) public health
				  facility;
(16)
				  "institutional pharmacy" means a pharmacy located in an institutional
				  facility;
(17) "licensee" means a
				  person who is licensed under AS 08.80 and this chapter;
(18) "live program" means an on-site
				  continuing education activity, including a lecture, symposium, live
				  teleconference, or workshop;
(19)
				  "sterile pharmaceutical" means a drug dosage form free from living
				  microorganisms (aseptic);
(20)
				  "wholesale distribution"
(A) means
				  distribution of prescription drugs to a person other than a consumer or
				  patient;
(B) does not include
(i) an activity described in
				  12 AAC 52.695; or
(ii) a manufacturer's distribution of the
				  manufacturer's own manufactured drugs or devices;
(21) "central pharmacy" means a
				  pharmacy providing remote pharmacy services through a telepharmacy
				  system;
(22) "personal supervision"
				  means supervision that includes visual or physical proximity to ensure adequate
				  safety controls;
(23) "pharmacy"
				  includes a central pharmacy and a remote pharmacy;
(24) "remote pharmacy" means a facility that
				  provides pharmacy services, including the storage and distribution of
				  prescription drugs, drug regimen review, and patient counseling through a
				  telepharmacy system;
(25) "still
				  image capture" means a specific image captured electronically from a video or
				  other image capture device;
(26)
				  "store and forward" means a video or still image record that is saved
				  electronically for future review;
(27) "telepharmacy system" means a system
				  under the direct supervision of a licensed pharmacist that monitors the
				  dispensing and distribution of prescription drugs and provides for related drug
				  use review and patient counseling services through a computer link and a video
				  link with sound;
(28) "accredited
				  provider" means an individual, institution, organization, association,
				  corporation, or agency that is recognized by the ACPE as able to provide
				  quality continuing education programs;
(29) "filling pharmacist" means a pharmacist
				  participating in shared pharmacy services that processes or fills a
				  prescription order for a patient;
(30) "filling pharmacy" means a pharmacy
				  participating in shared pharmacy services that processes or fills a
				  prescription order for a patient;
(31) "requesting pharmacist" means a
				  pharmacist participating in shared pharmacy services that forwards a
				  prescription order to another participating pharmacy or pharmacist to be
				  processed or filled;
(32)
				  "requesting pharmacy" means a pharmacy participating in shared pharmacy
				  services that forwards a prescription order to another participating pharmacy
				  to be processed or filled;
(33)
				  "shared pharmacy services" means a system allowing the processing by a
				  participating pharmacist or a pharmacy of a request from another participating
				  pharmacist or pharmacy to process or fill a prescription drug order, including
				  dispensing, drug utilization review, claims adjudication, refill
				  authorizations, therapeutic interventions, and institutional order
				  review;
(34) "dispenser" means a
				  practitioner who delivers a controlled substance to an ultimate user or
				  research subject under the lawful order of a practitioner; in this paragraph
				  "delivers" includes the prescribing and administering of a controlled substance
				  and the packaging, labeling, or compounding necessary to prepare the substance
				  for delivery;
(35) "profile" means
				  a compilation of data concerning a patient, a dispenser, a practitioner, or a
				  controlled substance.
(36) "PDMP"
				  means the prescription drug monitoring program's controlled substance
				  prescription database.
(37) "moral
				  turpitude" includes conduct that is considered contrary to community standards
				  of justice, honesty, or good morals.
(38) "pharmacy technician who holds a
				  national certification" means a pharmacy technician, licensed by the board, who
				  obtains and maintains an active national certification through the Pharmacy
				  Technician Certification Board (PTCB) or the National Healthcare Association
				  (NHA).
(39) "automated distribution
				  kiosk" means a vending machine that stores and distributes prescription drugs
				  or devices and maintains a record of transactions initiated or
				  completed;
(40) "manufacturer"
				  means a person or entity, including a virtual manufacturer, engaged in the
				  manufacturing of drugs or devices;
(41) "virtual manufacturer" means a
				  manufacturer that sells a prescription drug or device but never physically
				  possesses the product;
(42)
				  "NAPLEX" means the North American Pharmacy Licensing Examination, administered
				  by the National Association of Boards of Pharmacy.
(43) "Internet-based pharmacy" means a
				  person, entity, or Internet website that knowingly or intentionally delivers,
				  distributes, or dispenses, or offers or attempts to deliver, distribute, or
				  dispense prescription drugs or devices by means of the Internet;
(44) "standard of care" means care provided
				  by a licensee that is within the accepted standard of care that would be
				  provided in a similar setting by a reasonable and prudent licensee with similar
				  education, training, and experience.